Department of Hepatic Surgery

Key Figures

Total 36 staff:13 doctors, 23 nurses.

Total 42 ward beds


The Department of Hepatic Surgery is an important branch of the Department of General Surgery, a National Key Clinical Specialties. There are currently 13 surgeons with doctoral degree, including 7 professors and 2 associate professors. More than 1200 patients are admitted and approximately 1100 operative procedures (surgery, percutaneous ablation, ERCP, etc.) were performed each year.    

Clinical Services   

We provides therapy for hepatobiliary, pancreatic and spleen diseases, including primary (hepatocellular carcinoma, cholangiocarcinoma) and metastatic liver cancer, liver hemangioma, gallbladder /bile duct cancer and stones, benign and malignant pancreatic tumors, portal hypertension, spleen tumors and secondary hypersplenism,etc. Open surgery, laparoscopic surgery, robotic surgery, ERCP, and choledochoscope are routinely performed according to patient’s disease status. Most of the treatment choices are decided after multidisciplinary discussion.  


There are 2 Ph.D. supervisors and 4 master's supervisor in the department. We recruit 2-3 Ph.D. students, 3-4 graduate students and 15-20 surgical trainees each year. There are currently 8 Ph.D. students and 9 graduate students studying in our department. As one of the main surgical practice bases for surgical interns, we undertake teaching assignments for both undergraduate students and graduate students.


The main research interests of our department include both basic and clinical studies of liver cancer (including hepatocellular carcinoma and cholangiocarcinoma). We focused on the carcinogenesis, metastasis and targeted therapy of liver cancer. During the past 5 years, we have more than 20 foundations granted, including 8 National Natural Science Foundation of China, 1 National Science Foundation for Distinguished Young Scholars. At the same time, we have published more than 70 SCI papers in international journals, such as Hepatology, Nature Communication, Annals of Surgery, Oncogene, British Journal of Cancer, etc.

International Collaboration

Most of doctors have oversea studying experience in counties like USA, Japan, and Canada. We had collaborations with RIKEN (Rikagaku Kenkyusho/Institute of Physical and Chemical Research) from Japan and made achievements in tumor vaccine therapy against hepatocellular carcinoma. Results have been published in Clinical Cancer Research and other SCI cited journals. In addition, we encourage our Ph.D. students and graduate students to study abroad.  


Currently, there are 13 staffs in the department, including 7 professors, and 2 associate professors. 

Peng Baogang,M.D,Ph.D

Professor , Ph.D. Supervisor

Director of the Department of Hepatic Surgery

Li Shaoqiang ,M.D,Ph.D

Professor , Ph.D. Supervisor

Vice director of the Department of Hepatic Surgery

Kuang Ming ,M.D,Ph.D

Professor , Ph.D. Supervisor, 

Vice President of the 1st Affiliated Hospital of Sun Yat-sen University

Zhongshan School of Medicine, Sun Yat-Sen University.

He Qiang,M.D,Ph.D

Chief Physician, Master’s Supervisor

Zhou Qi,M.D,Ph.D

Chief Physician, Master’s Supervisor

Li Dongming,M.D

Chief Physician, Master’s Supervisor

Hua Yunpeng,M.D,Ph.D

Chief Physician, Master’s Supervisor

Hu Wenjie,M.D,Ph.D

Associate Chief Physician, Master’s Supervisor

Shen shunli,M.D,Ph.D

Associate Chief Physician, Master’s Supervisor